Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers Read more
Biopharma Process Systems & NIBSC to Lead Interactive Workshops for the Lyophilisation Conference 2019 Read more
PolyProx Therapeutics Raises £3.4m Seed Financing to Validate Novel Class of Drugs to Treat Cancer Read more
Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors Read more
Abbott Laboratories to lead Panel Discussion with Eli Lilly and MedImmune at SMi’s 4th annual Prefilled Syringes West Coast Conference Read more
EirGenix Enters Into Global License Agreement for the Commercialization of its Biosimilar Drug EG12014 Read more